Valuation: Avantor, Inc.

Market Cap 7.81B 6.86B 6.38B 5.85B 11B 752B 11.17B 75.76B 29.6B 370B 29.32B 28.69B 1,279B P/E 2026 *
30.9x
P/E 2027 * 26.5x
Enterprise Value 10.82B 9.51B 8.84B 8.11B 15.24B 1,042B 15.48B 105B 41.01B 512B 40.63B 39.75B 1,772B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.53x
Free-Float
95.54%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 17/08/2025
Director of Finance/CFO 50 23/06/2026
Chief Operating Officer - 09/11/2025
Director TitleAgeSince
Director/Board Member 60 21/04/2020
Chairman 69 31/12/2025
Director/Board Member 62 30/09/2021
Date Insider Type Main position Quantity % Market Cap.
21/06/26 Tax

Executive/Senior Manager

-3,010 0.0004%
08/05/26 Buy

Director

10,000 0.0015%
07/05/26 Free

Director

25,270 0.0037%
Change 5-day change 1-year change 3-year change Capi.($)
+0.79%+3.34% - - 7.81B
+2.29%+2.36%-18.56%-8.74% 180B
+1.46%+0.01%-10.47%-6.46% 107B
+1.58%+0.65%+6.73%+61.49% 60.29B
-1.13%-2.60%+27.02%+55.00% 50.19B
+2.22%-1.14%-15.63%-44.81% 43.08B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-19.61%-44.95% 27.61B
-7.67%-8.39%+24.55%-12.97% 23.1B
+1.63%-1.73%-7.11%-8.13% 20.86B
Average +0.57%-1.68%-1.63%-1.20% 55.17B
Weighted average by Cap. +1.27%-0.34%-6.81%+1.11%

Financials

2026 *2027 *
Net sales 6.5B 5.71B 5.31B 4.87B 9.15B 626B 9.3B 63.05B 24.63B 308B 24.4B 23.88B 1,064B 6.64B 5.83B 5.42B 4.97B 9.35B 639B 9.49B 64.37B 25.15B 314B 24.91B 24.38B 1,086B
Net income 244M 214M 199M 183M 343M 23.49B 349M 2.37B 924M 11.55B 915M 896M 39.92B 289M 254M 236M 217M 407M 27.83B 413M 2.8B 1.1B 13.68B 1.08B 1.06B 47.31B
Net Debt 3.01B 2.65B 2.46B 2.26B 4.24B 290B 4.31B 29.21B 11.41B 143B 11.31B 11.06B 493B 2.36B 2.07B 1.93B 1.77B 3.33B 227B 3.38B 22.91B 8.95B 112B 8.87B 8.68B 387B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Date Price Change Volume
24/07/26 US$11.44 +0.79% 12,278,629
23/07/26 US$11.35 +3.65% 15,496,603
22/07/26 US$10.95 -0.36% 7,261,913
21/07/26 US$10.99 +3.10% 11,084,936
20/07/26 US$10.66 -3.70% 9,383,290
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
11.44USD
Average target price
10.44USD
Spread / Average Target
-8.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AVTR Stock